Lacktman Discusses Joint Commission’s Decision to Hold Off on Proposed Changes to Telehealth Standards
October 11, 2017
Fierce Healthcare
Partner Nathaniel Lacktman was quoted in a Fierce Healthcare article, “Joint Commission Pulls Back Proposed Telehealth Standards,” covering the impact of the Joint Commission’s decision to not move forward with proposed changes that would have added new burdens to hospitals and ambulatory care clinics with telehealth programs. The proposal would have required hospitals providing direct-to-telehealth services to obtain informed consent from patients about the type of care and the modality used. The new standards were viewed by many as an additional burden.
“It’s really problematic for hospitals that spent a lot of time and resources and thoughtfulness in building out patient-centered innovative telehealth programs only to have a relatively esoteric Joint Commission standard come into effect and turn that all upside down,” Lacktman said.
But Lacktman said he also was pleased to see the Joint Commission back off the proposed standards and continue evaluating the feedback it had received. “I think that shows they are willing to listen to providers and hospitals in the telemedicine industry,” he said. “What that does mean is hospitals and telemedicine providers need to take time to submit comments or their feedback.”
“It’s really problematic for hospitals that spent a lot of time and resources and thoughtfulness in building out patient-centered innovative telehealth programs only to have a relatively esoteric Joint Commission standard come into effect and turn that all upside down,” Lacktman said.
But Lacktman said he also was pleased to see the Joint Commission back off the proposed standards and continue evaluating the feedback it had received. “I think that shows they are willing to listen to providers and hospitals in the telemedicine industry,” he said. “What that does mean is hospitals and telemedicine providers need to take time to submit comments or their feedback.”
People
Related News
April 3, 2026
In the News
David Rosen Weighs in on FDA's Pharma PR Crackdown – 'Stick to the Data'
Foley & Lardner LLP partner David Rosen shared insights on the regulatory challenges pharmaceutical companies face when publicly communicating around new cancer therapies in the MM+M article, “When a podcast becomes promotion: Inside the FDA’s warning shot at ImmunityBio.”
April 2, 2026
In the News
Susan Poll Klaessy and Adrienne Walker Named Chair and Vice Chair of Foley’s Bankruptcy & Business Reorganizations Practice
Foley & Lardner LLP partner Susan Poll Klaessy was appointed chair of the firm’s global Bankruptcy & Business Reorganizations Practice Group. Partner Adrienne Walker will serve as vice chair, supporting the continued growth and strategic direction of the practice.
April 1, 2026
In the News
Foley Featured on Top 10 Sales of 2025 List by Golf Inc.
Foley & Lardner LLP advised on two transactions named among Golf Inc.’s Top 10 Sales of 2025.